CytoDyn CEO calls Citron Research report 'false', updates on coronavirus clinical trials
CytoDyn Inc (OTCQB:CYDY) CEO Nader Pourhassan addressed the recent report published by short seller Citron Research, entitled "SEC must immediately halt this stock promotion scheme."
What's more, Pourhassan talked about the firm's two US-based coronavirus clinical trials, and its anticipated Phase 3 clinical trial with the NIH in Mexico.
Видео CytoDyn CEO calls Citron Research report 'false', updates on coronavirus clinical trials канала Proactive
What's more, Pourhassan talked about the firm's two US-based coronavirus clinical trials, and its anticipated Phase 3 clinical trial with the NIH in Mexico.
Видео CytoDyn CEO calls Citron Research report 'false', updates on coronavirus clinical trials канала Proactive
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
CytoDyn expects to exceed 75-patient enrollment in its coronavirus-focused Phase 2 clinical trial
OptiBiotix Health CEO updates on new deal with Actial Farmaceutica and launch of WellBiome
CytoDyn CEO says firm can be one of the top biotech companies in the world, pending clinical success
A look inside hedge funds | Marketplace Whiteboard
CytoDyn shares manuscript of potential coronavirus treatment to show validity of study's findings
Bushveld Minerals CEO says growth is still very much part of the story despite pandemic
planarTECH snowed-under with demand for its face masks
Powerhouse Energy CEO updates on commercial development and plans for future rollout
CytoDyn continues to works on licensing deals as FDA continues its review on patient data
CytoDyn Inc reveals adjustment to its HIV monotherapy treatment in 'major' announcement
Quadrise Fuels team details significant new agreement with international chemicals firm
CytoDyn sees impressive results with Leronlimab on very ill COVID-19 patients
CytoDyn hopes to convince FDA & federal gov't to grant approvals with coronavirus patient data
Warren Buffett On Why He'll Never Sell a Share of Coke Stock
CytoDyn's therapy used to treat New York coronavirus patients shows 'immunological benefits'
Kate Garraway Gives an Emotional Update on Husband Derek Draper | Good Morning Britain
CytoDyn reveals positive data on metastatic triple-negative breast cancer trial
CytoDyn to work with Mexican National Institutes of Health to treat coronavirus patients
CytoDyn's leronlimab 'working beautifully' in metastatic triple-negative breast cancer patients
CytoDyn continues to report strong results from COVID-19 patients using Leronlimab